ENTO insider transaction filings
Entero Therapeutics, Inc. — 5 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-01-08. Screen ENTO transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ENTO between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Entero Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-08 | 4 | Romano Sarah — Chief Financial Officer | Sale (S): 727 @ $0.64 | EDGAR |
| 2024-10-10 | 4 | Romano Sarah — Chief Financial Officer | Sale (S): 476 @ $0.45 | EDGAR |
| 2024-07-03 | 4 | Romano Sarah — Chief Financial Officer | Sale (S): 621 @ $1.07 | EDGAR |
| 2024-07-03 | 4 | SAPIRSTEIN JAMES — Chairman and CEO, Director | Sale (S): 1,289 @ $1.07 | EDGAR |
| 2024-06-12 | 4 | KHOSLA CHAITAN PHD — Director | Grant/award (A): 24,889 @ $0 | EDGAR |
Recent 8-K events — Entero Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-07-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-28 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | EDGAR |
| 2026-04-13 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ENTO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →